What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing is to inform investors and analysts that WellPoint, Inc. will be reaffirming its previously issued full-year 2009 earnings per share (EPS) guidance during upcoming meetings and communications scheduled between December 15 and December 24, 2009. It serves as a disclosure under Regulation FD to ensure all parties receive the same information simultaneously.

Does this filing contain any updated financial guidance or new projections?

No, this filing does not contain any updated financial guidance or new projections. It explicitly states that the company's officers expect to 'reaffirm' the EPS guidance for the full year 2009 that was previously provided in a Form 8-K on December 1, 2009. The purpose is to confirm existing expectations, not to change them.

What are the risks and uncertainties mentioned in the filing?

The filing includes a standard safe harbor statement that lists numerous potential risks and uncertainties that could affect WellPoint's future results. These include government regulation, healthcare cost trends, premium rate increases, provider contracting, competitor pricing, enrollment and product mix changes, Medicare and Medicaid program risks, financial strength rating downgrades, litigation and investigations, information systems, Blue Cross and Blue Shield Association licensing, intangible asset impairment, employee retention, data security, market conditions, dividend restrictions, and general economic downturns.

Is the information in this filing considered 'filed' for legal purposes?

No, the filing explicitly states that none of the information furnished in this report shall be deemed to be 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be incorporated by reference into any filing under the Securities Act of 1933. This means it's primarily for informational disclosure under Regulation FD rather than a formal filing that triggers certain legal liabilities.

ELV 8-K: Regulation FD — Dec 14, 2009

Summary

This Form 8-K filing from WellPoint, Inc. (now Elevance Health) on December 14, 2009, primarily serves to inform investors about upcoming communications with securities analysts and investors. During the period from December 15 to December 24, 2009, WellPoint's officers intended to reaffirm the company's full-year 2009 earnings per share (EPS) guidance previously provided on December 1, 2009. This communication is important for investors as it signals confidence in the company's near-term financial performance and reaffirms existing expectations without providing new guidance. The filing also includes a standard safe harbor statement under the Private Securities Litigation Reform Act of 1995. This statement outlines the forward-looking nature of certain statements made by the company and lists various risks and uncertainties that could materially affect actual results. While not detailing specific business events, the reaffirmation of guidance suggests a stable outlook at that time, which is crucial for investors assessing the company's operational and financial trajectory.

Key Highlights

1WellPoint, Inc. (ELV) is reaffirming its full-year 2009 earnings per share (EPS) guidance.
2This reaffirmation is expected to be communicated to securities analysts and investors between December 15 and December 24, 2009.
3The company is referencing its previous Form 8-K filing from December 1, 2009, for the initial guidance.
4The filing includes a safe harbor statement regarding forward-looking statements, outlining potential risks and uncertainties.
5This report does not contain new financial guidance or material events; it focuses on reinforcing existing expectations.
6The intention is to provide investor confidence by confirming prior financial outlooks.
7No new information is being 'filed' for regulatory purposes, but rather disclosed under Regulation FD.

Elevance Health, Inc. 8-K Report, Regulation FD Disclosure (Dec 14, 2009)

Summary

Key Highlights

Frequently Asked Questions